When most people see "90% cacao" on a label, they read it as a statement about flavor -- intensely bitter, not for everyone. That's true. But in the context of prostate health, 90% cacao is a proxy for something more specific: polyphenol density. The higher the cacao percentage, the higher the concentration of the flavanol compounds that are the subject of a growing body of evidence in prostate and urinary health research.
This article explains the science behind Relief's formulation -- not to make claims the evidence doesn't support, but to give you an honest account of what the compounds in a 90% cacao square contain, what the research says about each one, and why combining them in a food-format delivery vehicle makes biological sense.
What's Inside 90% Cacao
High-percentage dark chocolate is one of the most polyphenol-dense foods in the human diet. The relevant compounds are not generic antioxidants -- they are specific flavanols with distinct mechanisms of action: epicatechin, catechin, and procyanidins. These are the same compound classes studied in cardiovascular, inflammatory, and increasingly, prostate health contexts.
The distinction between eating a piece of dark chocolate and taking a standardized cacao extract is real and worth naming. Most clinical studies use purified or standardized extracts -- which means the dose is controlled and the compound concentration is verified. A food-format square cannot make the same claim. What it can offer is a consistent, high-polyphenol base delivered through a format that people actually use every day -- and as we discuss below, daily consistency is not a small variable in how well any supplement works.
Flavonoids: What the Evidence Shows
A 2025 meta-analysis of flavonoid supplementation in men at risk for prostate concerns found a PSA reduction of -0.64 and an odds ratio of 0.41 for relevant prostate endpoints across four included studies. This is early-stage evidence -- meta-analyses of this type reflect the state of the research, not a proven clinical recommendation -- but the signal is consistent with the broader mechanistic literature.
Cocoa polyphenol extracts have shown antiproliferative effects on prostate cancer cells in vitro. Animal studies using cocoa extract have demonstrated reduced experimentally-induced prostate hyperplasia. The language matters here: "in vitro" means cell culture studies, not human trials. These findings establish biological plausibility, not clinical proof. What they suggest is that the flavanol compounds in cacao have mechanisms of action relevant to prostatic tissue -- which is why they are a sensible ingredient in a prostate support formulation.
Quercetin, a flavonoid found in high concentrations in dark chocolate and plant foods, has been studied more directly in urological contexts. A double-blind RCT published in Urology found quercetin significantly improved symptoms of chronic pelvic pain syndrome vs. placebo. Epicatechin, another major flavanol in high-cacao chocolate, has shown vasodilatory effects relevant to urinary flow. These are supporting data points, not standalone treatment evidence -- but together, they make the flavonoid case.
Beta-Sitosterol: The Most Evidence-Backed Compound in the Stack
Beta-sitosterol is a plant sterol with the strongest clinical evidence base of any non-prescription compound for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). A Cochrane review and multiple subsequent randomized controlled trials show statistically significant improvements in International Prostate Symptom Score (IPSS) and maximum urinary flow rate compared to placebo, at doses of 60-195 mg/day over 6-12 weeks.
The mechanism: beta-sitosterol appears to inhibit 5-alpha reductase activity (the enzyme that converts testosterone to dihydrotestosterone, a driver of prostate tissue growth) and to reduce prostatic inflammation. Importantly, beta-sitosterol does not shrink the prostate. Clinical trials have not demonstrated significant reduction in prostate volume. What it does show, consistently, is improvement in urinary flow metrics and symptom burden -- which is the outcome most men with mild-to-moderate BPH are actually trying to address.
This is an important distinction from prescription medications like finasteride, which does reduce prostate volume over time. Beta-sitosterol operates differently -- and the honest scope of what it does should be the framing you use to evaluate it. For men with mild-to-moderate symptoms who are not candidates for or do not want prescription intervention, the evidence for beta-sitosterol is the most credible of any OTC option in the category.
Relief Classic is built around stated-dose beta-sitosterol, zinc, and flavonoids -- each ingredient disclosed, no proprietary blend math. One square a day, every day.
See the Relief Classic ingredient breakdownZinc: The Prostate's Primary Mineral
The prostate accumulates zinc at higher concentrations than any other soft tissue in the human body. Zinc-dependent enzymes play roles in testosterone metabolism, inflammatory regulation, and cellular signaling within prostatic tissue. Studies have shown that men with BPH have lower prostatic zinc concentrations than men with normal prostate histology.
The supplementation evidence for zinc is less clean than for beta-sitosterol. There is not a well-powered RCT showing that oral zinc supplementation directly reduces LUTS at clinically meaningful effect sizes. What the literature does support is zinc as a supportive and biologically necessary nutrient for prostatic tissue health -- not a standalone treatment, but a sensible inclusion in a stack alongside compounds with direct mechanism evidence. Standard supplemental dosing: 15-30 mg/day elemental zinc.
One additional note: zinc interacts with the flavonoid compounds in cacao. Research on phytochemical-mineral interactions suggests that flavanols may influence zinc absorption and tissue uptake. The precise magnitude of this interaction in a food-format delivery vehicle has not been studied in a controlled trial. The interaction is real and biologically plausible; the clinical significance of it in this specific context is not yet quantified.
Why the Delivery Vehicle Is Not a Marketing Decision
The scientific literature on prostate supplements consistently identifies a gap between what compounds are capable of in controlled trial conditions and what they actually deliver in real-world use. The gap is not primarily formulation quality. It is adherence.
Beta-sitosterol requires consistent daily intake over 6-12 weeks to reach the tissue concentrations studied in clinical trials. A supplement taken for 10 days and abandoned -- which is the modal outcome for capsule-format prostate supplements based on supplement adherence data -- will not produce the effects shown in 12-week RCTs. This is obvious when stated directly, but almost no brand in the category communicates it clearly.
- A patented cocoa extract composition has already formalized the combination of flavonoids, lipids, and beta-sitosterol as a validated formulation logic
- Food-linked routines show higher adherence than standalone supplement routines across multiple supplement categories
- A sensory experience (taste and texture) encodes the habit into memory in a way that an inert capsule cannot -- creating a positive feedback loop that sustains the routine
- One object, one moment, no water required: the friction of the daily act is minimal
None of this is a claim that the cacao matrix improves bioavailability of beta-sitosterol or that chocolate is a superior delivery vehicle from an absorption standpoint. The clinical data does not support that claim and we are not making it. What the behavioral evidence does support is that the format of a supplement is not incidental to its efficacy -- because a supplement taken every day for 12 weeks performs the science; a supplement taken for 10 days does not.
Honest Scope of Claims
Relief's formulation is built on the following evidence hierarchy: beta-sitosterol has the strongest human clinical evidence for LUTS improvement among OTC compounds. Zinc is a biologically necessary mineral for prostatic tissue function with supportive (not therapeutic) evidence for supplementation. Flavonoids -- including those concentrated in 90% cacao -- have preclinical and early clinical evidence for anti-inflammatory and prostate-relevant mechanisms, and are included as a rational complement to the primary stack.
What Relief does not claim: that these compounds treat, prevent, or cure any disease. That the cacao format improves absorption. That results are guaranteed at any timeline. The clinical data shows meaningful improvement in mild-to-moderate LUTS symptoms after 6-12 weeks of consistent use -- and consistent use is the rate-limiting variable Relief is designed to address.
When to See a Clinician
OTC prostate support is appropriate for men with mild-to-moderate lower urinary tract symptoms who have had a recent normal PSA and prostate exam. It is not appropriate as a substitute for clinical evaluation if your symptoms are new, rapidly worsening, accompanied by pain, blood in urine, or difficulty completely emptying your bladder. If you have not had a PSA test in the past year and are over 50, schedule one. Non-prescription support works alongside clinical care -- not instead of it.